Skip to main content
. 2025 Dec 11;16(1):61. doi: 10.21037/qims-24-1606

Table 1. Clinical characteristics of 595 patients with GST and GS.

Clinical characteristics GST-L (n=164) GS-L (n=13) Puni Pmulti GST-S (n=329) GS-S (n=89) Puni Pmulti
Sex 0.014†* 0.054† 0.002†** 0.008**
   Male 83 (50.6) 2 (15.4) 171 (52.0) 30 (33.7)
   Female 81 (49.4) 11 (84.6) 158 (48.0) 59 (76.3)
Age (years) (M ± SD) 59.85±12.25 55.15±12.06 0.184‡ 60.80±10.30 56.70±9.35 <0.001‡*** 0.322
Symptom 0.378† <0.001†*** 0.222
   0 56 (34.1) 7 (53.8) 110 (33.4) 55 (61.8)
   1 72 (43.9) 4 (30.8) 176 (53.5) 33 (37.1)
   2 36 (22.0) 2 (15.4) 43 (13.1) 1 (1.1)

Except where indicated, data are numbers of tumors, with percentages in parentheses. *, P<0.05; **, P<0.01; ***, P<0.001. Calculated with the χ2 test (†) and independent sample t-test (‡). Puni/Pmulti, value from the univariate or multivariate analysis. Symptom 0/1/2, asymptomatic/symptoms but no hematemesis/melena, hematemesis and/or melena. GS, gastric schwannoma; GST, gastric stromal tumor; GST-L/GS-L/GST-S/GS-S, large or small GST/GS; M ± SD, mean ± standard deviation.